Ratio Therapeutics - Crunchbase Company Profile & Funding

Ratio Therapeutics may be growing as evidenced by its recent $50 million Series B financing, which is aimed at advancing targeted radiotherapies for cancer treatment. Additionally, the …

CouponFollow Extension

$50
OFF

Ratio Therapeutics - Crunchbase Company Profile & Funding

6 days from now

Ratio Therapeutics may be growing as evidenced by its recent $50 million Series B financing, which is aimed at advancing targeted radiotherapies for cancer treatment. Additionally, the …

crunchbase.com

$50
OFF

Rasio Therapeutics - Recent News & Activity - Crunchbase

6 days from now

Nov 26, 2021 · News • Feb 6, 2024 Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment Funding Round • Nov 26, 2021

crunchbase.com

$50
OFF

The Week’s 10 Biggest Funding Rounds: Quantinuum

6 days from now

Jan 19, 2024 · Founded in 2021, this is the company’s first round with a disclosed amount, per Crunchbase. 9. Ratio Therapeutics, $50M, biotech: Boston-based Ratio Therapeutics, a …

crunchbase.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

yahoo.com

$1.75
OFF

Novartis Strengthens Radiopharma Leadership With Ratio …

6 days from now

3 days ago · This latest partnership follows a surge of investment within the radiopharmaceutical space. In May, Novartis acquired Mariana Oncology in a $1.75bn deal, inheriting the latter’s …

pharmaceutical-technology.com

$20
OFF

Ratio Therapeutics Announces $20M Series A Financing To …

6 days from now

BOSTON, Feb. 1, 2023 /PRNewswire/ -- Ratio Therapeutics Inc., a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of cancer, …

prnewswire.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

biospace.com

$50000000
OFF

Series B - Ratio Therapeutics - 2024-01-17 - Recent News

6 days from now

Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …

crunchbase.com

$10.55
OFF

Victory Capital Management Inc. Sells 16,794 Shares Of Sarepta ...

6 days from now

1 day ago · The company has a quick ratio of 3.03, a current ratio of 3.84 and a debt-to-equity ratio of 0.93. The company has a market capitalization of $10.55 billion, a PE ratio of 88.40 …

marketbeat.com

$20.33
OFF

Segall Bryant & Hamill LLC Has $20.33 Million Stock Position In ...

6 days from now

1 day ago · The company has a current ratio of 10.36, a quick ratio of 9.15 and a debt-to-equity ratio of 3.32. The business has a fifty day simple moving average of $55.15 and a 200 day …

marketbeat.com

$29.23
OFF

Jennison Associates LLC Lowers Position In Apellis ... - MarketBeat

6 days from now

16 hours ago · The company has a debt-to-equity ratio of 1.91, a current ratio of 4.36 and a quick ratio of 3.73. The stock's 50-day moving average is $29.23 and its 200 day moving average is …

marketbeat.com